Yuying Tian

Key Laboratory Of Digital Hepatobiliary Surgery
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Nanoadjuvant and recombinant hemagglutinin protein-based mucosal influenza nanovaccine confers protection against lethal viral challenge in mice.

Nanoadjuvant and recombinant hemagglutinin protein-based mucosal influenza nanovaccine confers protection against lethal viral challenge in mice.

Journal: International journal of biological macromolecules

Published: July 18, 2025

Molecular pathological characteristics and mechanisms of the liver in metabolic disease-susceptible transgenic pigs.

Molecular pathological characteristics and mechanisms of the liver in metabolic disease-susceptible transgenic pigs.

Journal: Life sciences

Published: August 18, 2024

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs.

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs.

Journal: International journal of nanomedicine

Published: July 09, 2024

Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.

Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.

Journal: International immunopharmacology

Published: September 25, 2023

NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment.

NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 08, 2023

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

Journal: Human gene therapy

Published: August 30, 2023

A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.

A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.

Journal: Virology

Published: August 29, 2023

Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus.

Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus.

Journal: Journal of gastroenterology

Published: July 20, 2023

Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.

Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.

Journal: Frontiers in immunology

Published: June 06, 2023

An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma.

An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: March 03, 2023

Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant.

Spotlight on NLRP6 and Tumor Research Situation: A Potential Cancer Participant.

Journal: Journal of immunology research

Published: January 18, 2023

mRNA vaccines: A novel weapon to control infectious diseases.

mRNA vaccines: A novel weapon to control infectious diseases.

Journal: Frontiers in microbiology

Published: August 01, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026